SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-17-019068
Filing Date
2017-07-26
Accepted
2017-07-26 17:12:01
Documents
1
Period of Report
2017-07-24

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 7863
  Complete submission text file 0000899243-17-019068.txt   9455
Mailing Address 201 ELLIOTT AVE. WEST, SUITE 230 SEATTLE WA 98119
Business Address 201 ELLIOTT AVE. WEST, SUITE 230 SEATTLE WA 98119 206-788-4545
ALPINE IMMUNE SCIENCES, INC. (Issuer) CIK: 0001626199 (see all company filings)

IRS No.: 208969493 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1

Mailing Address C/O ALPINE IMMUNE SCIENCES, INC. 201 ELLIOTT AVE. WEST, SUITE 230 SEATTLE WA 98119
Business Address
PENG STANFORD L (Reporting) CIK: 0001711352 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37449 | Film No.: 17983683